Li Kaili, Hu Xiaoxue, Lu Quanyi, Zhang Heng, Zhou Jiayi, Tian Shijing, Zhou Fachun
Department of Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Infect Drug Resist. 2023 Jul 20;16:4729-4740. doi: 10.2147/IDR.S418752. eCollection 2023.
To evaluate the risk factors and prognosis of patients with acute cholangitis recurrence.
A total of 503 patients with acute cholangitis admitted to the First Affiliated Hospital of Chongqing Medical University between July 2013 and January 2022 were included in this retrospective observational study, who were followed up for 360 days and divided into relapse group and non-recurrence group according to the recurrence of acute cholangitis. Risk factors and prognosis of patients with acute cholangitis recurrence were analyzed by univariate, multivariate analyses and proportional hazards model.
A total of 161 patients with recurrent acute cholangitis were identified. Recurrent acute cholangitis usually occurred within 125 days; Escherichia faecalis, and was the most common positive record both in blood and bile culture. In the multivariate analysis, abdominal pain (OR = 2.448, 95% CI = 1.196-5.010, = 0.014), bile stones (OR = 2.429, 95% CI = 1.024-5.762, = 0.044), diabetes (OR = 1.790, 95% CI = 1.007-3.182, = 0.047), pathogen (OR = 3.305, 95% CI = 1.932-5.654, <0.001), and chronic kidney disease (OR = 2.500, 95% CI = 1.197-5.221, = 0.015) may be ascertained as the risk factors of acute cholangitis recurrence. The recurrence of acute cholangitis was identified as an independent risk factor for patient death (HR = 4.524, 95% CI = 1.426-14.357, = 0.010) by Cox proportional-hazards regression.
Abdominal pain, bile stones, diabetes and chronic kidney disease may be risk factors of acute cholangitis recurrence. Patients with recurrent acute cholangitis have poor prognosis and high mortality. Early control of recurrent risk factors and active intervention are beneficial to high-risk patients.
评估急性胆管炎复发患者的危险因素及预后。
本回顾性观察研究纳入了2013年7月至2022年1月期间重庆医科大学附属第一医院收治的503例急性胆管炎患者,对其进行360天的随访,并根据急性胆管炎的复发情况分为复发组和非复发组。通过单因素分析、多因素分析和比例风险模型分析急性胆管炎复发患者的危险因素及预后。
共确定161例复发性急性胆管炎患者。复发性急性胆管炎通常发生在125天内;粪肠球菌是血液和胆汁培养中最常见的阳性记录。多因素分析中,腹痛(OR = 2.448,95%CI = 1.196 - 5.010,P = 0. 014)、胆结石(OR = 2.429,95%CI = 1.024 - 5.762,P = 0. 044)、糖尿病(OR = 1.790,95%CI = 1.007 - 3.182,P = 0. 047)、病原体(OR = 3.305,95%CI = 1.932 - 5.654,P<0. 001)和慢性肾脏病(OR = 2.500,95%CI = 1.197 - 5.221,P = 0. 015)可能被确定为急性胆管炎复发的危险因素。通过Cox比例风险回归分析,急性胆管炎复发被确定为患者死亡的独立危险因素(HR = 4.524,95%CI = 1.426 - 14.357,P = 0. 010)。
腹痛、胆结石、糖尿病和慢性肾脏病可能是急性胆管炎复发的危险因素。复发性急性胆管炎患者预后较差,死亡率较高。早期控制复发危险因素并积极干预对高危患者有益。